Catalyst Event

Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Earnings Release

From Akros SCHK HK-Korea High Beta Factor Index (ASHKHBT)

4/27/2026, 12:00:00 AM

Earnings ReleaseSentiment: Positive

Biocytogen Pharmaceuticals reported Q1 2026 results on 2026-04-27, showing a turnaround to net income of CNY 104.03 million and 73.68% revenue growth; Medium importance estimated due to strong growth and profitability shift.

Korean Translation

바이오사이토젠(Biocytogen Pharmaceuticals)이 2026년 4월 27일 1분기 실적을 발표함. 순이익 1억 403만 위안으로 흑자 전환하고 매출이 전년 동기 대비 73.68% 증가하여 주가에 긍정적 영향이 예상됨.

Related Recent Events

View Full Timeline